210 related articles for article (PubMed ID: 1710169)
21. 31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors.
Constantinidis I; Braunschweiger PG; Wehrle JP; Kumar N; Johnson CS; Furmanski P; Glickson JD
Cancer Res; 1989 Nov; 49(22):6379-82. PubMed ID: 2804984
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo 31P nuclear magnetic resonance measurements of metabolic changes post radiation.
Mahmood U; Alfieri AA; Ballon D; Traganos F; Koutcher JA
Cancer Res; 1995 Mar; 55(6):1248-54. PubMed ID: 7882317
[TBL] [Abstract][Full Text] [Related]
23. Effect of radiation-induced injury of tumor bed stroma on metastatic spread of murine sarcomas and carcinomas.
Milas L; Hirata H; Hunter N; Peters LJ
Cancer Res; 1988 Apr; 48(8):2116-20. PubMed ID: 3349483
[TBL] [Abstract][Full Text] [Related]
24. Deuterium nuclear magnetic resonance imaging of the developmental pattern of tumour blood flow.
Burney IA; Maxwell RJ; Griffiths JR; Field SB
EXS; 1992; 61():357-61. PubMed ID: 1377555
[No Abstract] [Full Text] [Related]
25. Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSall tumors.
Kalmus J; Okunieff P; Vaupel P
Cancer Res; 1990 Jan; 50(1):15-9. PubMed ID: 2293549
[TBL] [Abstract][Full Text] [Related]
26. Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy.
Evelhoch JL; Bissery MC; Chabot GG; Simpson NE; McCoy CL; Heilbrun LK; Corbett TH
Cancer Res; 1988 Sep; 48(17):4749-55. PubMed ID: 3409216
[TBL] [Abstract][Full Text] [Related]
27. Changes in blood flow of growing experimental tumor determined by the clearance of 133Xe.
Siracká E; Pappová N; Pípa V; Durkovský J
Neoplasma; 1979; 26(2):173-7. PubMed ID: 582462
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of tumor cell proliferation by dexamethasone: 31P NMR studies of RIF-1 fibrosarcoma cells perfused in vitro.
Abraha A; Shim H; Wehrle JP; Glickson JD
NMR Biomed; 1996 Jun; 9(4):173-8. PubMed ID: 9015804
[TBL] [Abstract][Full Text] [Related]
29. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
Kozin SV; Kozina LV
Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
[TBL] [Abstract][Full Text] [Related]
30. Correlation of radiobiological assays of hypoxic fraction with phosphorus-31 magnetic resonance spectroscopy across multiple tumor lines.
Li SJ; Jin GY; Fish BL; Moulder JE
Radiat Res; 1995 Jul; 143(1):45-53. PubMed ID: 7597143
[TBL] [Abstract][Full Text] [Related]
31. [31P-MR spectroscopy of the brain in patients with anorexia nervosa: characteristic differences in the spectra between patients and healthy control subjects].
Rzanny R; Freesmeyer D; Reichenbach JR; Mentzel HJ; Pfleiderer SO; Klemm S; Gerhard UJ; Blanz B; Kaiser WA
Rofo; 2003 Jan; 175(1):75-82. PubMed ID: 12525985
[TBL] [Abstract][Full Text] [Related]
32. [Experimental studies on evaluation of the effects of radiotherapy and chemotherapy in urogenital tumors using 31P-magnetic resonance spectroscopy].
Kanimoto Y; Suzuki Y; Okada K
Hinyokika Kiyo; 1994 Apr; 40(4):295-301. PubMed ID: 8191967
[TBL] [Abstract][Full Text] [Related]
33. In vivo 31P-nuclear magnetic resonance study of the response of a murine mammary tumor to different doses of gamma-radiation.
Sijens PE; Bovée WM; Seijkens D; Los G; Rutgers DH
Cancer Res; 1986 Mar; 46(3):1427-32. PubMed ID: 3943104
[TBL] [Abstract][Full Text] [Related]
34. 31P NMR spectroscopy can predict the optimum interval between fractionated irradiation doses.
Murata O; Sakurai H; Mitsuhashi N; Hasegawa M; Yamakawa M; Kurosaki H; Hayakawa K; Niibe H
Anticancer Res; 1998; 18(6A):4297-301. PubMed ID: 9891481
[TBL] [Abstract][Full Text] [Related]
35. Cellular energetics measured by phosphorous nuclear magnetic resonance spectroscopy are not correlated with chronic nutrient deficiency in multicellular tumor spheroids.
Freyer JP; Schor PL; Jarrett KA; Neeman M; Sillerud LO
Cancer Res; 1991 Aug; 51(15):3831-7. PubMed ID: 1855200
[TBL] [Abstract][Full Text] [Related]
36. Radiation dose-dependent changes in tumor metabolism measured by 31P nuclear magnetic resonance spectroscopy.
Mahmood U; Alfieri AA; Thaler H; Cowburn D; Koutcher JA
Cancer Res; 1994 Sep; 54(18):4885-91. PubMed ID: 8069854
[TBL] [Abstract][Full Text] [Related]
37. Early metabolic response to tumor necrosis factor in mouse sarcoma: a phosphorus-31 nuclear magnetic resonance study.
Shine N; Palladino MA; Patton JS; Deisseroth A; Karczmar GS; Matson GB; Weiner MW
Cancer Res; 1989 Apr; 49(8):2123-7. PubMed ID: 2702653
[TBL] [Abstract][Full Text] [Related]
38. Hypoxic cell cytotoxin tirapazamine induces acute changes in tumor energy metabolism and pH: a 31P magnetic resonance spectroscopy study.
Aboagye EO; Dillehay LE; Bhujwalla ZM; Lee DJ
Radiat Oncol Investig; 1998; 6(6):249-54. PubMed ID: 9885940
[TBL] [Abstract][Full Text] [Related]
39. Quantitative determination of tumor blood flow and perfusion via deuterium nuclear magnetic resonance spectroscopy in mice.
Kim SG; Ackerman JJ
Cancer Res; 1988 Jun; 48(12):3449-53. PubMed ID: 2836055
[TBL] [Abstract][Full Text] [Related]
40. Growth inhibition in response to estrogen withdrawal and tamoxifen therapy of human breast cancer xenografts evaluated by in vivo 31P magnetic resonance spectroscopy, creatine kinase activity, and apoptotic index.
Kristensen CA; Kristjansen PE; Brünner N; Quistorff B; Spang-Thomsen M
Cancer Res; 1995 Sep; 55(18):4146-50. PubMed ID: 7664292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
